CONMED Corp (CNMD) › Cost of RevenueCONMED Corp (CNMD) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2009: $357.41M2010: $348.34M2011: $350.14M2012: $361.30M2013: $350.29M2014: $336.00M2015: $337.47M2016: $355.19M2017: $365.35M2018: $390.52M2019: $430.38M2020: $402.16M2021: $442.60M2022: $474.23M2023: $568.50M2024: $573.98M2025: $624.25M$624.25M2009Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$624.25M+8.8%2024$573.98M+1.0%2023$568.50M+19.9%2022$474.23M+7.1%2021$442.60M+10.1%2020$402.16M-6.6%2019$430.38M+10.2%2018$390.52M+6.9%2017$365.35M+2.9%2016$355.19M+5.3%2015$337.47M+0.4%2014$336.00M-4.1%2013$350.29M-3.0%2012$361.30M+3.2%2011$350.14M+0.5%2010$348.34M-2.5%2009$357.41M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share